silybin has been researched along with Cancer of Head in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YC; Hu, FW; Jan, CI; Lai, YC; Peng, CY; Yu, CC | 1 |
1 other study(ies) available for silybin and Cancer of Head
Article | Year |
---|---|
Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Topics: AC133 Antigen; ADAM Proteins; ADAM10 Protein; Aldehyde Dehydrogenase 1 Family; Amyloid Precursor Protein Secretases; Animals; Antigens, CD; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glycoproteins; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Incidence; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; Phenotype; Polycomb Repressive Complex 1; Prognosis; Retinal Dehydrogenase; Silybin; Silymarin | 2015 |